Paul G Higham, Chief Executive Officer, is a seasoned healthcare industry expert with extensive leadership experience in both large pharmaceutical and biotech companies. He has over 15 years C-Suite Biotech company experience. During the last 10 years, he has been CEO of two immuno-oncology development-stage companies.
He was Chief Executive Officer of Glycotope GmbH a glycobiology company focussing on immuno-therapeutics in oncology from 2016 to 2017 and before that CEO at Immatics Biotechnologies from 2008 to 2015. Through his leadership at Immatics, the company developed a number of peptide-based immunotherapies and has become one of the leading T-cell focused.
Current role
Chief Executive Officer at Kids
Chief Executive Officer at Saint Vincent's Services
Chief Executive Officer at Kemptville District Hospital
Chief Executive Officer at J.D. and Billy Hines Trucking, Inc. (HTI)
Chief Executive Officer at The Feinstein Group